University of Washington President Michael K. Young and Provost Ana Mari Cauce announced Monday the selection of Sean D. Sullivan as the new dean of the UW School of Pharmacy, effective Sept. 15. The appointment is subject to approval by the UW Board of Regents.
“Dr. Sullivan occupies a very prominent position nationally and internationally in pharmacy practice and education,” said Cauce. “We have had the great good fortune to have him on our faculty for the past 22 years. We are excited about his moving into this important leadership position in our School of Pharmacy. We are especially gratified when we find the talent we are looking for to be essentially home grown.”
Sullivan has been at the UW since 1992, promoting through the ranks to associate professor in 1997 and full professor in 2001. He became the School’s associate dean for research in 2010. He holds a joint appointment as professor of Health Services in the School of Public Health and is the Stergachis Family Endowed Director of the UW Pharmaceutical Outcomes Research and Policy Program (PORPP), and co-Director of the UW Centers for Comparative and Health Systems Effectiveness (CHASE Alliance). He also holds adjunct appointments in the School of Medicine, the Public Health Sciences Division at the Fred Hutchinson Cancer Research Center, and at Group Health Research Institute.
He earned his bachelor’s degree in pharmacy from Oregon State University in 1983, a master’s degree in administrative and economic sciences from the University of Texas in 1986, and a Ph.D. in health economics and policy from the University of California, Berkeley, in 1991.
He has authored more than 300 journal articles, book chapters, task force reports and organizational and governmental publications. In many of these writings, he has assessed the evidence and applications of medical technology in relation to health insurance coverage and reimbursement decisions. His research interests include technology assessment, medical decision-making and economic evaluation of medical technology. He is the past chair of the Academy of Managed Care Pharmacy executive committee on the AMCP Format for Formulary Submissions – the United States evidence-based guidelines for formulary decision-making.
Sullivan currently serves on the Medicare Evidence Development and Coverage Advisory Committee. He is also on the editorial boards of Value in Health, PharmacoEconomics, European Journal of Health Economics and Core Evidence. He is a past president of the International Society for Pharmacoeconomics and Outcomes Research. He was recently awarded the Stephen G. Avey Lifetime Achievement Award from the Academy of Managed Care Pharmacy.
His annual salary will be $252,000.